Zoek een onderzoeksproject
Andere zoekoptie(s)
71 Resultaat/Resultaten
Gefinancierd door een IRDiRC-lid = Member of a ERN =
Onderzoeksprojecten

Ontario
OTTAWA
Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
Children's Hospital of Eastern Ontario
Newborn Screening Ontario

Ontario
OTTAWA, ONTARIO
Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
University of Ottawa
Department of Epidemiology and Community Medicine

Baden-Württemberg
HEIDELBERG
Longitudinal Study of Urea Cycle Disorders
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion für Neuropädiatrie und Stoffwechselmedizin

LAZIO
ROMA
The Italian Expanded newborn screening program
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare

Cataluña
BELLATERRA
Biosensors for the monitoring of Hereditary Metabolic Diseases. Development and evaluation of functional prototypes for conceptual validation
Universitat Autònoma de Barcelona
Grupo de Sensores y Biosensores

Cataluña
ESPLUGUES DE LLOBREGAT
Biosensors for the monitoring of Hereditary Metabolic Diseases. Development and evaluation of functional prototypes for conceptual validation
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu
Grupo de investigación del Metabolismo energético mitocondrial

Washington
ADDRESS: NOT PROVIDED - US
Basic and clinical studies in immune function and metabolism
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Metabolic engineering in humans: altered gut microbes as a therapeutic platform
Institution: Information not provided - US

Region Stockholm
STOCKHOLM
Inborn errors of endocrinology and metabolism
Karolinska Institutet - Solna
Department of Molecular Medicine and Surgery

Suisse Alémanique
ZÜRICH
Identification and Validation of Relevant Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Abteilung für Stoffwechselkrankheiten

Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Sachsen
LEIPZIG
High-throughput mutation analysis for known and novel single-gene causes of kidney stones and related disorders
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Endokrinologie, Nephrologie, Rheumatologie

AUVERGNE-RHONE-ALPES
GRENOBLE
Physiopathological studies of Lowe's syndrome and Dent's disease, two clinical entities with common molecular basis?
CHU de Grenoble et des Alpes - Institut de biologie et de pathologie
Laboratoire de Génétique Moléculaire: maladies héréditaires et oncologie

ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

CAMPANIA
NAPOLI
Role of phosphoinositide metabolism in the structure and function of the Golgi complex and in the pathogenesis of Lowe syndrome
TIGEM - Telethon Institute of Genetics and Medicine
Laboratorio di Ricerca

EMILIA ROMAGNA
FERRARA
RNA-based therapeutics for OTC deficiency
Università degli Studi di Ferrara - Dip. di Scienze della vita e biotecnologie
Dipartimento di Scienze della vita e biotecnologie

JAPAN
AICHI
Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University

JAPAN
AICHI
Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University

JAPAN
GIFU
Study to provide several lines of evidence which directly connecting to managements for target diseases of newborn screening
Gifu University Graduate School of Medicine
Department of Pediatrics

JAPAN
TOKYO
Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development
Research Institute

WIEN
ADDRESS: NOT PROVIDED - AT
European post marketing registry for RAVICTI® (Glycerolphenylbutyrat), oral liquid, in cooperation with the European registry and network for intoxication type metabolic diseases - E-IMD (RRPE) - AT
Institution: Information not provided - AT

Cataluña
ESPLUGUES DE LLOBREGAT
Personalized medicine in the genetic defects of neurotransmission in pediatrics. New approach based on the metabolism of the neuronal synapse (amino acid mediated neurotransmission diseases)
Hospital Sant Joan de Déu Barcelona
Unidad de Enfermedades Metabólicas Congénitas

Madrid
ADDRESS: NOT PROVIDED - ES
A Long-Term Follow-up Study to Evaluate Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Adults With Late-Onset OTC Deficiency - ES
Institution: Information not provided - ES

Madrid
MADRID
Bioinformatics developments based on network and systems biology to identify new candidate genes for rare genetic diseases
Fundación Jiménez Díaz
Área de Genética y Genómica

Washington
ADDRESS: NOT PROVIDED - US
A powerful web-based discovery platform for rare disease genetics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mitigating mitochondrial epigenetics in bone remodeling by hydrogen sulfide
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cell and gene replacement strategies for arginase deficiency
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The role of inhibitory neurons in microcephaly and seizure caused by asparagine synthetase (asns) deficiency
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Pharmacologic augmentation of gene therapy with n-carbamylglutamate (ncg)
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Gene therapy for urea cycle disorders
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Barriers to achieving efficient gene therapy
Institution: Information not provided - US

Suisse Alémanique
ZURICH
Establishment of in vivo CRISPR-Cas base editor approaches to treat monogenetic liver diseases
ETH Zurich - Hönggerberg campus
Institute of Molecular Health Sciences

OOST-VLAANDEREN
GENT
SNAP: Klinische studie voedingsstoffen bij volwassen PKU
Ghent University Hospital - UZ Gent
CEMA - Centrum voor Erfelijke Metabole Aandoeningen

OOST-VLAANDEREN
GENT
PANDA: Een cross-sectioneel onderzoek om bloedaminozuurniveaus te meten bij PKU-kinderen op een eiwitvervanger
Ghent University Hospital - UZ Gent
CEMA - Centrum voor Erfelijke Metabole Aandoeningen

Alberta
EDMONTON
Formulation and efficacy of a corn-derived phenylalanine ammonia-lyase for the treatment of phenylketonuria (PKU) and hyperphenylalaninemias
University of Alberta
Department of Biological Sciences

Colombie-Britannique
VANCOUVER
Formulation and efficacy of a corn-derived phenylalanine ammonia-lyase for the treatment of phenylketonuria (PKU) and hyperphenylalaninemias
Child & Family Research Institute

Colombie-Britannique
VANCOUVER
Application of Stable Isotopes to Determine Protein Requirements in Children with Phenylketonuria (PKU)
University of British Columbia
CFRI - Child and Family Research Institute

Colombie-Britannique
VANCOUVER
Minimally Invasive 13C-Breath Test to Examine Phenylalanine Metabolism in Children with Phenylketonuria
University of British Columbia
CFRI - Child and Family Research Institute

Baden-Württemberg
HEIDELBERG
Evaluation of a novel measuring method for the determination of phenylalanine concentrations in whole blood and a possible application for home monitoring
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion für Neuropädiatrie und Stoffwechselmedizin

Baden-Württemberg
REUTLINGEN
Multicentre Study Project to Evaluate the New Generation of Protein Supplements With Glycomacropeptide (GMP) in Patients With Phenylketonuria (PKU) Aged 10 Years and Older Over a 16 Week Period.
Kreiskliniken Reutlingen
Klinik für Kinder- und Jugendmedizin

Berlin
BERLIN
CORD : Collaboration On Rare Diseases
Geschäftsstelle BIH
Berliner Institut für Gesundheitsforschung

Mecklenburg-Vorpommern
ROSTOCK

TOSCANA
SIENA
Identification and preclinical analysis of therapeutic molecules for the treatment of alkaptonuria
Università degli Studi di Siena - Presidio San Miniato
Sezione di Biochimica e Biologia Molecolare

TOSCANA
SIENA
Proteomic and clinical study of alkaptonuria physiopathology and set up a therapy for the treatment of ochronosis
Università degli Studi di Siena - Presidio San Miniato
Sezione di Biochimica e Biologia Molecolare

TOSCANA
SIENA
Clinical Development of Nitisinone for Alkaptonuria
Università degli Studi di Siena - Presidio San Miniato
Sezione di Biochimica e Biologia Molecolare

TOSCANA
SIENA
Preclinical study of therapeutic agents for the treatment of ochronotic arthropathy
Università degli Studi di Siena - Presidio San Miniato
Sezione di Biochimica e Biologia Molecolare

UMBRIA
PERUGIA
Comprehensive analysis of the molecular pathogenesis of gyrate atrophy towards the rationalization and the optimization of the therapy with vitamin B6
Università degli Studi di Perugia
Dipartimento di Medicina Sperimentale

Andalucía
SEVILLA
Biomedical research and clinical innovation in hereditary retinal dystrophies: towards personalized medicine in rare diseases
Hospital Universitario Virgen del Rocío
Unidad de Medicina Maternofetal, Genética y Reproducción

Aragón
ZARAGOZA
Design and development of a new phenylalanine test for family management of phenylketonuria
Universidad de Zaragoza. Facultad de Ciencias
Departamento de Bioquimica y Biologia Molecular y Celular (Facultad de Ciencias)

Cataluña
BARCELONA
Adeno-associated viral gene therapy with AAV9-GCDH to correct glutaric aciduria type 1 in Gcdh -1- mice
Fundació Clínic per a la Recerca Biomèdica
Grupo Terapia génica y cáncer

Madrid
MADRID
Multicentre study in glutaric aciduria type I: Clinic, radiologic and neurocognitive characterization - National registry development
Hospital Universitario 12 de Octubre
Unidad Pediátrica de Enfermedades Mitocondriales y Enfermedades Metabólicas Hereditarias

Washington
ADDRESS: NOT PROVIDED - US
Clinical and molecular studies of malformations
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Investigations of methylmalonic acidemia and related disorders
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
A new view of pah allostery - correlation with disease-associated alleles
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Creating a paper-based phenylalanine test for personalized therapy monitoring by patients with phenylketonuria
Institution: Information not provided - US

Suisse Alémanique
ZÜRICH
The effect of cofactors and vitamins on homocysteine and methylmalonic acid metabolism in health and disease
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Abteilung für Stoffwechselkrankheiten

Niedersachsen
GÖTTINGEN
AAV-mediated gene therapy for molybdenum cofactor deficiency type B
Institut für Humangenetik der Universität Göttingen
Institut für Humangenetik

Washington
ADDRESS: NOT PROVIDED - US
Zebrafish models of human disease
Institution: Information not provided - US
Multicentrische onderzoeksprojecten
- University of Ottawa
- Faculty of Medicine -
- Institut Fédératif de Biologie
- Laboratoire de Biochimie
- IRB Barcelona - Instituto de Investigación Biomédica
- Transportadores de aminoácidos y enfermedad
- Instituto de Biomedicina de Valencia (CSIC)
- Unidad de Genética y Medicina Molecular
- Oxford University Begbroke Science Park
- Zyoxel Limited
- The Sheffield Children's Hospital
- Department of Clinical Chemistry
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- CHU de Grenoble et des Alpes - Institut de biologie et de pathologie
- Laboratoire de Génétique Moléculaire: maladies héréditaires et oncologie
- Muséum National d'Histoire Naturelle
- Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
- Institut de Recherche en Santé - Université de Nantes
- L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
- Newcastle upon Tyne Hospitals NHS Trust
- John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

Ontario
OTTAWA, ONTARIO
CIMDRN- Canadian Inherited Metabolic Diseases Research Network

OCCITANIE
TOULOUSE
Réseau Sud-Ouest des erreurs innées du métabolisme

Cataluña
BARCELONA
EUGINDAT: European genomics initiative on disorders of plasma membrane amino acid transporters

Comunidad Valenciana
VALENCIA
BioMeder - Genes, proteins and signaling pathways in rare diseases

Oxfordshire
BEGBROKE
TissueGEN: THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT

South Yorkshire
SHEFFIELD
MetBioNet - National Metabolic Biochemistry Network

Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)

AUVERGNE-RHONE-ALPES
GRENOBLE
French network for genetic, cellular and clinical researches on Lowe syndrome

ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy

PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health

LAZIO
ROMA
UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)

Tyne & Wear
NEWCASTLE UPON TYNE